Comparative efficacy and tolerability of currently approved incretin mimetics: a systematic analysis of placebo-controlled clinical trials
He suspected this was due to the hormone stimulating the release of insulin independently of its ability to raise blood glucose levels
76 Exenatide is composed of 39 amino acids and shares 53% sequence identity to human GLP-1
Several factors contribute to these elevated costs: Patent protection Most GLP-1 medications are still under patent, preventing generic competition Manufacturing complexity These are biologic medications that require specialized production processes Research and development costs Pharmaceutical companies invest heavily in clinical trials and regulatory approval Market positioning These medications are often priced as premium treatments Without insurance coverage, patients face the full retail price, which can make these medications financially inaccessible for many people who need them
2024 Mar;119(3):599-627 Alba Miguns-Gmez # 1, ngela Casanova-Mart # 1, M Teresa Blay 1, Ximena Terra 1, Ral Beltrn-Debn 1, Esther Rodrguez-Gallego 1, Anna Ardvol 1, Montserrat Pinent 1
Diabetes Obes Metab 24(1):94105 Zaazouee MS et al (2022) Semaglutide for the treatment of type 2 Diabetes Mellitus: A systematic review and network meta-analysis of safety and efficacy outcomes
